Immunogenicity, Reactogenicity and Safety of 2 Doses of an Adjuvanted Herpes Zoster Subunit Vaccine Administered 2, 6 or 12 Months Apart in Older Adults: Results of a Phase III, Randomized, Open-Label, Multicenter Study
Vaccine（2017）
Key words
Varicella-zoster virus,Herpes zoster,Shingles,Vaccine,HZ/su,Immunogenicity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined